Peer-Review Supports CLEOs Ovarian Cancer Detection Tech
Filed with ASX · · 3 pages · English
Earlier from CLEO Diagnostics
- Cleo Completes Design Transfer
- Completion of First Triage Test Clinical Validation Study
- Pause in Trading
- Cleo Delivers Early Progress on Development Program
- Appendix 4E and Preliminary Financial Report
Later from CLEO Diagnostics
- CLEO Appoints Partner to Commence U.S. Market Access Program
- COV Appoints CRO to Manage US Ovarian Cancer Clinical Trials
- COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
- Cleo Commences US Regulatory Process with FDA
- CLEO Selects U.S. Clinical Trial Sites
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics